Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

318
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
318
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Validation of the newly introduced Deauville Score 5a in patients treated for advanced-stage classic Hodgkin Lymphoma.

Blood advances·2026
Same author

Reducing breast cancer recurrences with CDK4/6 inhibitor treatment of HR-positive, HER2-negative early stage breast cancer from a societal perspective.

Health economics review·2026
Same author

An Evaluation of Pretrained Generative Models for Augmenting Small Health Data: Comparative Modeling Study.

Journal of medical Internet research·2026
Same author

Assessment of Risks and Outcomes of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Stem Cell Transplant Recipients Including Potentially Undiagnosed Cases-A Multicenter Canadian Study.

Current oncology (Toronto, Ont.)·2026
Same author

Incidence and Management Trends in Advanced Head and Neck Non-Melanoma Skin Cancer in Ontario.

Current oncology (Toronto, Ont.)·2026
Same author

A Randomized Trial Evaluating Personalized Versus Guideline-Based Well Follow-Up Strategies for Patients with Early Breast Cancer: Feasibility Outcomes.

Current oncology (Toronto, Ont.)·2026

相关实验视频

Updated: May 23, 2025

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

474

使用生成模型增加不足的瘤临床试验:验证研究.

Samer El Kababji1,2, Nicholas Mitsakakis2, Elizabeth Jonker2

  • 1School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.

Journal of medical Internet research
|March 7, 2025
PubMed
概括

生成型模型,特别是序列合成,可以模拟患者以克服低临床试验积累率,可能挽救不足的研究. 这种方法有效地取代了多达40%的被移除患者,保持了研究完整性.

关键词:
人工智能的人工智能是人工智能.临床试验复制的复制数据集数据集数据集生成型模型是一种生成型模型.机器学习是机器学习.瘤学 在瘤学方面.病人的病人的病人的病.招聘工作 招聘工作 招聘工作这是一个追溯的回顾.模拟患者的模拟患者模拟模拟是指一个模拟模拟.研究积累的研究.验证验证的时间

更多相关视频

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.0K
Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

6.3K

相关实验视频

Last Updated: May 23, 2025

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

474
Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.0K
Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

6.3K

科学领域:

  • 临床试验 临床试验
  • 人工智能的人工智能
  • 瘤学研究研究

背景情况:

  • 患者积累不足是临床试验中的一个重大挑战,导致研究不足和成本增加.
  • 使用生成模型模拟患者的现有方法在范围和评估方面存在局限性.
  • 现实世界的数据可以作为外部控制,但积累问题影响所有研究部门.

研究的目的:

  • 综合评估生成模型在模拟额外患者中的实用性,以解决临床试验积累不足的问题.
  • 评估不同生成模型在增强试验数据方面的有效性.

主要方法:

  • 来自9个已完成的癌症试验的10个数据集的回顾性分析.
  • 通过删除10-50%的患者和使用生成模型来取代他们,模拟了不足的积累.
  • 评估了四种生成模型 (序列合成,贝叶斯网络,GAN,VAE) 和引导抽样.
  • 使用决策协议,估计协议,标准差异和CI重叠指标复制已发表的分析.

主要成果:

  • 序列合成表明高性能 (88-100%的决策协议) 达到40%的患者移除.
  • 引导抽样显示了中度的有效性 (78-89%的决策同意).
  • 在早期和晚些时候招募的患者之间没有发现系统差异,支持生成模型的有效性.
  • 观察到生成的数据与训练数据的高准确性 (黑林格距离).

结论:

  • 序列合成可以模拟瘤学试验的完整数据集,目标招募率仅为60%,为不足的研究提供了替代方案.
  • 生成型模型显示出拯救不良临床试验的潜力.
  • 需要进一步的研究来证实这些发现,并将其推广到其他疾病.